Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study)

American Journal of Cardiology

Volumn 114, Issue 1, 2014, Pages 29-35

  Ko, Young Guk ^a   Won, Hoyoun ^a   Shin, Dong Ho ^a   Kim, Jung Sun ^a   Kim, Byeong Keuk ^a   Choi, Donghoon ^a   Hong, Myeong Ki ^a   Bae, Jang Ho ^b   Lee, Sahng ^c   Lim, Do Sun ^d   Jang, Yangsoo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Konyang University College of Medicine   (South Korea)

^c Eulji University School of Medicine   (South Korea)

^d College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; ROSUVASTATIN;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEART INFARCTION SIZE; HUMAN; HYPERTENSION; INTENSIVE CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANTICOAGULANTS; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLACEBOS; PROSPECTIVE STUDIES; PYRIMIDINES; REPUBLIC OF KOREA; SECONDARY PREVENTION; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84902254150     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.059     Document Type: Article

References (26)

1. G. Patti, V. Pasceri, G. Colonna, M. Miglionico, D. Fischetti, G. Sardella, A. Montinaro, and G. Di Sciascio Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278
2. V. Pasceri, G. Patti, A. Nusca, C. Pristipino, G. Richichi, G. Di Sciascio ARMYDA Investigators Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study Circulation 110 2004 674 678
3. R. Merla, N.K. Reddy, F.W. Wang, B.F. Uretsky, A. Barbagelata, and Y. Birnbaum Meta-analysis of published reports on the effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis Am J Cardiol 100 2007 770 776
4. K.H. Yun, M.H. Jeong, S.K. Oh, S.J. Rhee, E.M. Park, E.M. Lee, N.J. Yoo, N.H. Kim, Y.K. Ahn, and J.W. Jeong The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome Int J Cardiol 137 2009 246 251
5. C. Briguori, G. Visconti, A. Focaccio, B. Golia, A. Chieffo, A. Castelli, M. Mussardo, M. Montorfano, B. Ricciardelli, and A. Colombo Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction J Am Coll Cardiol 54 2009 2157 2163
6. J.S. Kim, J. Kim, D. Choi, C.J. Lee, S.H. Lee, Y.G. Ko, M.K. Hong, B.K. Kim, S.J. Oh, D.W. Jeon, J.Y. Yang, J.R. Cho, N.H. Lee, Y.H. Cho, D.K. Cho, and Y. Jang Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial JACC Cardiovasc Interv 3 2010 332 339
7. S. Post, M.C. Post, B.J. van den Branden, F.D. Eefting, M.J. Goumans, P.R. Stella, H.W. van Es, T.X. Wildbergh, B.J. Rensing, and P.A. Doevendans Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial Catheter Cardiovasc Interv 80 2012 756 765
8. J.Y. Hahn, H.J. Kim, Y.J. Choi, S.H. Jo, H.J. Kim, S. Lee, K.J. Ahn, Y.B. Song, J.H. Choi, S.H. Choi, Y.J. Choi, K.H. Lee, S.H. Lee, and H.C. Gwon Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Am Heart J 162 2011 1026 1033
9. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
10. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group N Engl J Med 312 1985 932 936
11. H.M. Gweon, S.J. Kim, T.H. Kim, S.M. Lee, Y.J. Hong, S.J. Rim, B.K. Hong, P.K. Min, Y.W. Yoon, and H.M. Kwon Evaluation of reperfused myocardial infarction by low-dose multidetector computed tomography using prospective electrocardiography (ECG)-triggering: comparison with magnetic resonance imaging Yonsei Med J 51 2010 683 691
12. J.S. Kim, Y.G. Ko, S.J. Yoon, J.Y. Moon, Y.J. Kim, B.W. Choi, D. Choi, and Y. Jang Correlation of serial cardiac magnetic resonance imaging parameters with early resolution of ST-segment elevation after primary percutaneous coronary intervention Circ J 72 2008 1621 1626
13. M.A. Albert, E. Danielson, N. Rifai, P.M. Ridker PRINCE Investigators Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study JAMA 286 2001 64 70
14. A. Undas, K.E. Brummel, J. Musial, K.G. Mann, and A. Szczeklik Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation Circulation 103 2001 2248 2253
15. S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, M. Tiemann, H. Rutten, S. Fichtlscherer, H. Martin, and A.M. Zeiher HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J Clin Invest 108 2001 391 397
16. S.E. Nissen, S.J. Nicholls, I. Sipahi, P. Libby, J.S. Raichlen, C.M. Ballantyne, J. Davignon, R. Erbel, J.C. Fruchart, J.C. Tardif, P. Schoenhagen, T. Crowe, V. Cain, K. Wolski, M. Goormastic, E.M. Tuzcu ASTEROID Investigators Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
17. G. Patti, M. Chello, V. Pasceri, D. Colonna, A. Nusca, M. Miglionico, A. D'Ambrosio, E. Covino, and G. Di Sciascio Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy J Am Coll Cardiol 48 2006 1560 1566
18. I.A. Paraskevaidis, E.K. Iliodromitis, I. Ikonomidis, L. Rallidis, E. Hamodraka, J. Parissis, A. Andoniadis, S. Tzortzis, and M. Anastasiou-Nana The effect of acute administration of statins on coronary microcirculation during the pre-revascularization period in patients with myocardial infraction Atherosclerosis 223 2012 184 189
19. R. Scalia, M.E. Gooszen, S.P. Jones, M. Hoffmeyer, D.M. Rimmer 3rd, S.D. Trocha, P.L. Huang, M.B. Smith, A.M. Lefer, and D.J. Lefer Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice Circulation 103 2001 2598 2603
20. S.P. Jones, S.D. Trocha, and D.J. Lefer Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion Arterioscler Thromb Vasc Biol 21 2001 2059 2064
21. G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomized trial J Am Coll Cardiol 54 2009 558 565
22. P.H. Jones, M.H. Davidson, E.A. Stein, H.E. Bays, J.M. McKenney, E. Miller, V.A. Cain, J.W. Blasetto, and S.S. Group Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial) Am J Cardiol 92 2003 152 160
23. Z.Q. Zhao, and J. Vinten-Johansen Postconditioning: reduction of reperfusion-induced injury Cardiovasc Res 70 2006 200 211
24. S. Bellosta, R. Paoletti, and A. Corsini Safety of statins: focus on clinical pharmacokinetics and drug interactions Circulation 109 2004 III50 III57
25. P.D. Martin, P.D. Mitchell, and D.W. Schneck Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers Br J Clin Pharmacol 54 2002 472 477
26. A.A. Bulhak, A.V. Gourine, A.T. Gonon, P.O. Sjoquist, G. Valen, and J. Pernow Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level Acta Physiol Scand 183 2005 151 159